Molecular characterization of a multiethnic group of patients with type 3 von Willebrand disease

被引：0
|
作者：
Baronciani, L
Cozzi, G
Canciani, MT
Lattuada, A
Peyvandi, F
Srivastava, A
Federici, AB
Mannucci, PM
机构：
[1] Univ Milan, Maggiore Hosp, IRCCS, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[2] CMC Hosp, Dept Hematol, Vellore, Tamil Nadu, India
来源：
THROMBOSIS AND HAEMOSTASIS | 1999年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
884
引用
收藏
页码：282 / 282
页数：1
相关论文
共 50 条
  • [31] VON WILLEBRAND FACTOR INHIBITORS IN TYPE 3 VON WILLEBRAND DISEASE: CHALLENGES IN DIAGNOSIS
    Megdiche, F.
    Kassar, O.
    Krichen, I.
    Kallel, F.
    Ghorbel, M.
    Elloumi, M.
    Kallel, C.
    HAEMOPHILIA, 2020, 26 : 135 - 135
  • [32] Molecular characterization, recombinant protein expression, and mRNA analysis of type 3 von Willebrand disease: Studies of an Italian cohort of 10 patients
    Solimando, Maria
    Baronciani, Luciano
    La Marca, Silvia
    Cozzi, Giovanna
    Asselta, Rosanna
    Canciani, Maria Teresa
    Federici, Augusto B.
    Peyvandi, Flora
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (09) : 870 - 874
  • [33] An evaluation of von Willebrand factor (recombinant) therapy for adult patients living with severe type 3 von Willebrand disease
    Hancock, John M.
    Escobar, Miguel A.
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (03) : 157 - 161
  • [34] PREVALENCE OF VON-WILLEBRAND DISEASE IN CHILDREN - A MULTIETHNIC STUDY
    WERNER, EJ
    BROXSON, EH
    TUCKER, EL
    GIROUX, DS
    SHULTS, J
    ABSHIRE, TC
    JOURNAL OF PEDIATRICS, 1993, 123 (06): : 893 - 898
  • [35] Heterogeneity of von willebrand disease type 3 in a french cohort of 75 patients
    Boisseau, P.
    Fressinaud, E.
    Ternisien, C.
    Caron, C.
    Borel-Derlon, A.
    Trossaert, M.
    Lavenu-Blombed, C.
    Rothschild, C.
    Beziau, S.
    Susen, S.
    Veyradier, A.
    Goudemand, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 103 - 103
  • [36] Genetic defects in von Willebrand disease type 3 in Indian and Greek patients
    Gupta, P. K.
    Saxena, R.
    Adamtziki, E.
    Budde, U.
    Oyen, F.
    Obser, T.
    Schneppenheim, R.
    BLOOD CELLS MOLECULES AND DISEASES, 2008, 41 (02) : 219 - 222
  • [37] Molecular basis of von Willebrand disease type IIC Miami
    Schneppenheim, R
    Obser, T
    Wieding, JU
    Bergmann, F
    Drewke, E
    Luxemburg, B
    Budde, U
    31ST HEMOPHILIA SYMPOSIUM: HAMBURG 2000, 2002, : 203 - 207
  • [38] The effectiveness of screening of exon 28 in patients with Type 3 Von Willebrand disease
    Ravanbod, S.
    Enayat, S.
    Rassoulzadegan, M.
    Nasirnejad, F.
    Lari, Rastegar G.
    Chupan, A.
    Baghaipour, M. R.
    Jazebi, M.
    Ala, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 942 - 943
  • [39] Treatment for patients with type 3 von Willebrand disease and alloantibodies: a case report
    Franchini, M.
    Gandini, G.
    Giuffrida, A.
    De Gironcoli, M.
    Federici, A. B.
    HAEMOPHILIA, 2008, 14 (03) : 645 - 646
  • [40] The molecular basis of type 3 von Willebrand disease in a cohort of patients from the North-West of England
    Sutherland, M. S.
    Keeney, S.
    Bolton-Maggs, P. H. B.
    Hay, C. R. M.
    Will, A.
    Cumming, A. M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 75 - 75
12345